entertainment -WSS

entertainment

author：explore 2025-10-02 00:53:38 - browse：9

What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.

For more on what we cover, here are the year’s best CEOs; here are the worst; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： As obesity drug market grows, telehealth companies court payers

WSS

How to protect patients from sexual assault

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Vivek Ramaswamy made waves in the debate, much as in biotech

Ethical issues complicate the benefits of medical crowdfunding

California store owner shot dead in dispute over displaying Pride flag: Police

How the drug

focus

entertainment

focus

What does generative AI mean for health care? We asked experts

Listen: Biogen's potential pivot, & Illumina's next chapter

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The 10 drugs up first for Medicare price negotiation

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How the first Native Hawaiian psychiatrist helped diversify medicine

Jerome Adams on the need for new antivirals for Covid

Trans patients at the end of life deserve respect and dignity

Medicare details structure of new drug price negotiation program

Illumina names Agilent executive as new CEO

explore

'Make People Better': The CRISPR babies story you probably don't know

National associations that represent hospice owe an apology

People can get long Covid without testing positive for virus: Study

How the drug

Crinetics acromegaly drug succeeds in late

Listen: Biogen's potential pivot, & Illumina's next chapter

focus

knowledge

leisure time

focus